{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:05:29Z","timestamp":1791198329851,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.pharma.2009.06.003","type":"journal-article","created":{"date-parts":[[2009,8,9]],"date-time":"2009-08-09T04:09:57Z","timestamp":1249790997000},"page":"320-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Troubles psychiatriques et ganglions de la base\u00a0: une validation exp\u00e9rimentale"],"prefix":"10.1016","volume":"67","author":[{"given":"J.","family":"F\u00e9ger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Worbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Galineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2009.06.003_bib1","first-page":"3","article-title":"Mod\u00e8les exp\u00e9rimentaux de la maladie de Parkinson","volume":"60","author":"F\u00e9ger","year":"2002","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.pharma.2009.06.003_bib2","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.mt.6300185","article-title":"Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates","volume":"15","author":"Palfi","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.pharma.2009.06.003_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pharmthera.2005.05.003","article-title":"Using animal models to develop therapeutics for Tourette's syndrome","volume":"108","author":"Swerdlow","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharma.2009.06.003_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrd2217","article-title":"How can drug discovery for psychiatric disorders be improved","volume":"6","author":"Agid","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharma.2009.06.003_bib5","first-page":"19","article-title":"\u00c9tude sur une affection nerveuse caract\u00e9ris\u00e9e par de l\u2019incoordination motrice accompagn\u00e9e d\u2019\u00e9cholalie et de coprolalie","volume":"9","author":"Gilles de la Tourette","year":"1885","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharma.2009.06.003_bib6","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMra010032","article-title":"Tourette's syndrome","volume":"345","author":"Jankovic","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharma.2009.06.003_bib7","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1212\/WNL.57.8.1383","article-title":"Prevalence of tic in schoolchildren and association with placement in special education","volume":"57","author":"Kurlan","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2009.06.003_bib8","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0387-7604(03)90012-X","article-title":"Neurobiology of Tourette's syndrome: concepts of neuroanatomic localization and neurochemical abnormalities","volume":"25","author":"Singer","year":"2003","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharma.2009.06.003_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/brain\/awm278","article-title":"Neural corelates of tic severity and cognitive control in children with Tourette's syndrome","volume":"131","author":"Baym","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.pharma.2009.06.003_bib10","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(02)11526-1","article-title":"Tourette's syndrome","volume":"360","author":"Leckman","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pharma.2009.06.003_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.tins.2006.01.001","article-title":"Recent advances in Tourette's syndrome research","volume":"29","author":"Albin","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharma.2009.06.003_bib12","doi-asserted-by":"crossref","first-page":"13307","DOI":"10.1073\/pnas.0502624102","article-title":"Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette's syndrome","volume":"102","author":"Kalanithi","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharma.2009.06.003_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-0173(94)00007-C","article-title":"Functionnal anatomy of the basal ganglia: I. The cortico-basal ganglia-thalamo-cortical loop","volume":"20","author":"Parent","year":"1995","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharma.2009.06.003_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0165-0173(94)00008-D","article-title":"Functionnal anatomy of the basal ganglia: functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry","volume":"20","author":"Parent","year":"1995","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharma.2009.06.003_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functionnal anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharma.2009.06.003_bib16","series-title":"The basal ganglia and new surgical approaches for Parkinson's disease","first-page":"31","article-title":"The subthalamic nucleus and its connections: new electrophysiological and pharmacological data","author":"F\u00e9ger","year":"1997"},{"key":"10.1016\/j.pharma.2009.06.003_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0168-0102(02)00027-5","article-title":"Functional significance of the cortico-subthalamo-pallidal \u2018hyperdirect\u2019 pathway","volume":"43","author":"Nambu","year":"2002","journal-title":"Neurosci Res"},{"key":"10.1016\/j.pharma.2009.06.003_bib18","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1111\/j.1460-9568.2008.06229.x","article-title":"Evidence for a direct subthalamo-cortical loop circuit in the rat","volume":"27","author":"Degos","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharma.2009.06.003_bib19","series-title":"The biochemical basis of neuropharmacology","author":"Cooper","year":"2002"},{"key":"10.1016\/j.pharma.2009.06.003_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuroscience.2005.09.005","article-title":"Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia","volume":"137","author":"Matyas","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharma.2009.06.003_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pharma.2008.07.003","article-title":"Neuropsychopharmacologie du delta-9-t\u00e9trahydrocannabinol (THC)","volume":"66","author":"Costentin","year":"2008","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.pharma.2009.06.003_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0165-6147(00)01805-8","article-title":"Modulation of transmitter release via preynaptic cannbinoid receptors","volume":"22","author":"Schlicker","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharma.2009.06.003_bib23","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/brain\/awn054","article-title":"Cognitive deficits and striato-frontal dopamine release in Parkinson's disease","volume":"131","author":"Sawamoto","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.pharma.2009.06.003_bib24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/jnnp.49.4.381","article-title":"Depression in Parkinson's disease: a quantitative and qualitative analysis","volume":"49","author":"Gotham","year":"1986","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pharma.2009.06.003_bib25","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1099-1166(199909)14:9<711::AID-GPS4>3.0.CO;2-1","article-title":"Depression in patients with Parkinson's disease","volume":"14","author":"Cummings","year":"1999","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.pharma.2009.06.003_bib26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0166-2236(99)01415-0","article-title":"Recent advances in understanding the pathogenenesis of Huntington's disease","volume":"22","author":"Reddy","year":"1999","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharma.2009.06.003_bib27","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanims of neurodegneration in Huntington's disease","volume":"27","author":"Gil","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharma.2009.06.003_bib28","series-title":"The basal ganglia IV: new ideas and data on structure and function","first-page":"569","article-title":"Function of the basal ganglia in mental activity","author":"Laplane","year":"1994"},{"key":"10.1016\/j.pharma.2009.06.003_bib29","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/mds.1185","article-title":"Auto-activation deficit: a basal ganglia related syndrome","volume":"16","author":"Laplane","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.pharma.2009.06.003_bib30","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/brain\/awn045","article-title":"Disconnecting force from money: effects of basal ganglia damage on incentive motivation","volume":"131","author":"Schmidt","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.pharma.2009.06.003_bib31","first-page":"416","article-title":"Hemiballismus with logorrhea and thymo-affective dishinbition caused by hematoma of the left subthalamic nucleus","volume":"151","author":"Trillet","year":"1995","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.pharma.2009.06.003_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pneurobio.2005.09.005","article-title":"The functionnal role of the subthalamic nucleus in cognitive and limbic circuits","volume":"76","author":"Temel","year":"2005","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharma.2009.06.003_bib33","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1056\/NEJM199905133401905","article-title":"Transient acute depression induced by high-frequency deep-brain stimulation","volume":"340","author":"Beijani","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharma.2009.06.003_bib34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/mds.1174","article-title":"Mirthful laughter induced by subthalamic nucleus stimulation","volume":"16","author":"Krack","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.pharma.2009.06.003_bib35","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/mds.21098","article-title":"Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation","volume":"21","author":"Ardouin","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.pharma.2009.06.003_bib36","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0140-6736(02)11339-0","article-title":"Compulsions, Parkinson's disease, and stimulation","volume":"360","author":"Mallet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pharma.2009.06.003_bib37","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1073\/pnas.0610849104","article-title":"Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior","volume":"104","author":"Mallet","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharma.2009.06.003_bib38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","article-title":"Parallel organization of functionally segregated circuits linking basal ganglia and cortex","volume":"9","author":"Alexander","year":"1986","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pharma.2009.06.003_bib39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/brain\/awh008","article-title":"Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity","volume":"127","author":"Dale","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.pharma.2009.06.003_bib40","series-title":"Motivation, motor and sensory processes of the brain: electrical potentials, behaviour and clinical use","first-page":"584","article-title":"Brain mechanisms of intention and attention with introductory remarks on other volitionnal processes","author":"Hassler","year":"1980"},{"key":"10.1016\/j.pharma.2009.06.003_bib41","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.32.5.514","article-title":"The mysterious motor function of the basal ganglia","volume":"32","author":"Marsden","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2009.06.003_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0166-2236(90)90058-I","article-title":"Cognitive function in Parkinson's disease: from description to theory","volume":"13","author":"Brown","year":"1990","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharma.2009.06.003_bib43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0079-6123(00)26015-9","article-title":"Involvement of basal ganglia and orbitofrontal cortex in goal-directed behavior","volume":"126","author":"Hollerman","year":"2000","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.pharma.2009.06.003_bib44","series-title":"Neurobiology of addiction","author":"Koob","year":"2006"},{"key":"10.1016\/j.pharma.2009.06.003_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.psych.59.103006.093548","article-title":"Addiction and the brain antireward system","volume":"59","author":"Koob","year":"2008","journal-title":"Annu Rev Psychol"},{"key":"10.1016\/j.pharma.2009.06.003_bib46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0306-4522(94)00484-M","article-title":"Activity of pallidal neurons in the monkey during dyskinesia induced by injection of bicuculline in the external pallidum","volume":"65","author":"Matsumura","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharma.2009.06.003_bib47","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0165-6147(99)01334-6","article-title":"Recent advances in the pharmacology of quaternary salts of bicuculline","volume":"20","author":"Seutin","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharma.2009.06.003_bib48","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1093\/brain\/awh239","article-title":"Behavioural disorders induced by external globus pallidus dysfunction in primates: II. Anatomical study","volume":"127","author":"Francois","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.pharma.2009.06.003_bib49","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/nn1544","article-title":"The cerebellum communicates with basal ganglia","volume":"8","author":"Hoshi","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharma.2009.06.003_bib50","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1471-4159.1977.tb10649.x","article-title":"The 14C-deoxyglucose method for measurement of local cerebral glucose utilization: theory, procedures and normal values in the conscious and anesthetized rat","volume":"28","author":"Sokoloff","year":"1977","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharma.2009.06.003_bib51","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/brain\/awh220","article-title":"Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study","volume":"127","author":"Grabli","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.pharma.2009.06.003_bib52","doi-asserted-by":"crossref","unstructured":"Worbe Y, Baup N, Grabli D, Chaigneau M, Mounayar S, McCairn K, et al. Behavioral and movement disorders induced by local inhibitory dysfunction in primate striatum. Cerebral Cortex 2009;19:1844\u201356.","DOI":"10.1093\/cercor\/bhn214"},{"key":"10.1016\/j.pharma.2009.06.003_bib53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0165-1781(01)00219-0","article-title":"Repetitive behaviours in Tourette's syndrome and OCD with and without tics: what are the differences?","volume":"101","author":"Cath","year":"2001","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharma.2009.06.003_bib54","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1523\/JNEUROSCI.14-02-00599.1994","article-title":"Input-output organization of the sensorimotor striatum in the squirrel monkey","volume":"14","author":"Flaherty","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharma.2009.06.003_bib55","first-page":"614","article-title":"Informational analysis of the basal ganglia related system","volume":"150","author":"Percheron","year":"1994","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.pharma.2009.06.003_bib56","first-page":"2","article-title":"Cortical input to behaviorally characterized sites in GPe","volume":"472","author":"Morrow","year":"2008","journal-title":"Neurosci Abstract"},{"key":"10.1016\/j.pharma.2009.06.003_bib57","first-page":"1","article-title":"From basal ganglia to cerebral cortex: identification of cortial areas implicated in movement and behavioural disorders induced by external pallidum dysfunction in primate using positron emission tomography","volume":"472","author":"Galineau","year":"2008","journal-title":"Neurosci Abstract"},{"key":"10.1016\/j.pharma.2009.06.003_bib58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0306-4522(95)00535-8","article-title":"Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus","volume":"72","author":"Hassani","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharma.2009.06.003_bib59","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1460-9568.2000.00901.x","article-title":"Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiologic measurements","volume":"12","author":"Vila","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharma.2009.06.003_bib60","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.2402638","article-title":"Reversal of experimental parkinsonism by lesion of the subthalamic nucleus","volume":"249","author":"Bergman","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.pharma.2009.06.003_bib61","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1460-9568.1993.tb00505.x","article-title":"Reversal of rigidity and improvement in motor performance by subthalamic high frequency stimulation in MPTP-treated monkeys","volume":"5","author":"Benazzouz","year":"1993","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharma.2009.06.003_bib62","first-page":"405","article-title":"Deep brain stimulation for Parkinson's disease","volume":"86","author":"Benabid","year":"2001","journal-title":"Adv Neurol"},{"key":"10.1016\/j.pharma.2009.06.003_bib63","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0140-6736(98)05964-9","article-title":"Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus","volume":"353","author":"Vandewalle","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pharma.2009.06.003_bib64","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/jnnp.2004.043273","article-title":"Tourette's syndrome and deep brain stimulation","volume":"76","author":"Houeto","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pharma.2009.06.003_bib65","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/archneur.65.7.952","article-title":"Internal pallidal and thalamic stimulation in patients with Tourette's syndrome","volume":"65","author":"Welter","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharma.2009.06.003_bib66","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/mds.20302","article-title":"The pallidosubthalamic projection: an anatomical substrate for nonmotor functions of the subthalamic nucleus in primates","volume":"20","author":"Karachi","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.pharma.2009.06.003_bib67","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0006-8993(79)91066-7","article-title":"Experimental hemiballism in the monkey produced by unilateral kainic acid lesion in corpus luysi","volume":"171","author":"Hammond","year":"1979","journal-title":"Brain Res"},{"key":"10.1016\/j.pharma.2009.06.003_bib68","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1523\/JNEUROSCI.2384-08.2008","article-title":"High-frequency stimulation of the anterior subthalamic nucleus reduces stereotyped behaviors in primates","volume":"28","author":"Baup","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharma.2009.06.003_bib69","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa0708514","article-title":"Subthalamic nucleus stimulation in severe obsessive-compulsive disorder","volume":"359","author":"Mallet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharma.2009.06.003_bib70","first-page":"1192","article-title":"Deep brain stimulation for OCD and major depression","author":"Aouizerate","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharma.2009.06.003_bib71","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrn1119","article-title":"Looking into the functional architecture of the brain with diffusion MRI","volume":"4","author":"Le Bihan","year":"2003","journal-title":"Natur Rev Neurosci"},{"key":"10.1016\/j.pharma.2009.06.003_bib72","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.mri.2005.12.031","article-title":"Tracing neural ciruits in vivo with Mn-enhanced MRI","volume":"24","author":"Murayama","year":"2006","journal-title":"Magnet Res Imag"},{"key":"10.1016\/j.pharma.2009.06.003_bib73","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1162\/089892902760191171","article-title":"Functionnal MRI in the awake monkey: the missing link","volume":"14","author":"Orban","year":"2002","journal-title":"J Cognit Neuroci"},{"key":"10.1016\/j.pharma.2009.06.003_bib74","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrd2094","article-title":"Drug development for CNS disorders: strategies for balancing risk and reducing attrition","volume":"6","author":"Pangalos","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharma.2009.06.003_bib75","doi-asserted-by":"crossref","first-page":"7320","DOI":"10.1073\/pnas.89.16.7320","article-title":"Evolution of consciousness","volume":"89","author":"Eccles","year":"1992","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450909000881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450909000881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:27:25Z","timestamp":1757719645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450909000881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0003450909000881"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2009.06.003","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Troubles psychiatriques et ganglions de la base\u00a0: une validation exp\u00e9rimentale","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2009.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}